MCP connectors move to Linux Foundation governance as clinical trials begin adopting the standard for AI-integrated trial systems.

Astellas launches Phase 3 trial comparing setidegrasib vs docetaxel in KRAS G12D lung cancer patients, targeting a previously untreated patient population.

PDS0101 Plus Pembrolizumab achieved 39.3-month median overall survival in HPV16-positive head and neck cancer, published in JAMA Oncology.

IMVT-1402 missed its primary endpoint in a cutaneous lupus proof-of-concept trial, failing to show statistically significant improvement on CLASI-A score at wee ...

Tekton Research launches dedicated psychiatry team across 17 sites to address rater drift, diagnostic variability, and participant dropout in psychiatric trials ...

CBL-514 meets primary endpoint in Phase 2 Dercum's Disease trial, with 90% of patients achieving meaningful pain relief at ...

Barzolvolimab meets all primary and key secondary endpoints in Phase 3 CSU trials, advancing Celldex's mast cell-targeting ...

Roche's sefaxersen Phase 3 IgAN study met its primary endpoint, significantly reducing proteinuria versus placebo at 37 weeks ...

Vistagen's fasedienol shows positive results in open-label extension for social anxiety disorder, following two Phase 3 ...

Picture a screening visit at a busy research site. A coordinator sits across from a patient, laptop open, scanner nearby, eSource tool loading. She is maintaining eye contact, keeping the patient calm ...

FDA's 2026 shift to a single pivotal trial as the default approval standard forces sponsors to rethink Phase 3 design before the next IND meeting.

Merry Life Biomedical starts Phase 2 trial of TML-6, an oral drug targeting autophagy-lysosomal pathways in early Alzheimer's ...